Francesco Cognetti
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients.
Journal: Frontiers in oncology
Published: May 08, 2026
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities.
Journal: Current oncology (Toronto, Ont.)
Published: October 25, 2025
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 11, 2025
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 03, 2024
Awareness of genomic testing among patients with breast cancer in Europe.
Journal: Breast (Edinburgh, Scotland)
Published: July 12, 2024
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study.
Journal: Cancers
Published: October 13, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 28, 2023
Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 04, 2022
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: August 16, 2022
Palbociclib plus letrozole induces a complete metabolic response in metastatic breast cancer patient with idiopathic thrombocytopenia.
Journal: Recenti progressi in medicina
Published: June 27, 2022
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).
Journal: Tumori
Published: June 08, 2022
The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient's dream study.
Journal: Frontiers in oncology
Published: June 02, 2022
Last Updated: 09/26/2026